Emerging Developments in Gene Therapy and DNA Vaccines (Technical Insights)
Emerging Developments in Gene Therapy and DNA Vaccines (Technical Insights)
RELEASE DATE
28-May-2003
28-May-2003
REGION
Global
Global
Research Code: D260-01-00-00-00
SKU: HC01301-GL-TR_05590
$3,950.00
In stock
SKU
HC01301-GL-TR_05590
Description
This report covers developments in gene therapy and DNA vaccines, including new technologies; novel applications; market analysis; and key developments
Table of Contents
Overview and Perspective
- Overview
- The Technologies
- Scope and Methodology
The Marketplace
- Market Analysis
- Barriers to Commercialization
The History of Gene Therapy
Types of Technologies
- The Beginning
- The Setbacks
- The Middle Ground
Alternatives to Gene Transfection
- Retroviruses
- Adenoviruses
- Adeno-Associated Virus
- Naked DNA
- Chemical and Physical Methods
- Other Types of Technologies
Gene Therapy Market
Market Sectors that Will Be Affected by Gene Therapy
Barriers to Commercialization
Emerging Developments in Gene Therapy and DNA Vaccines (Technical Insights), Technology Developments
Vector and Gene-Transfer Technologies
Gene Therapies for Specific Disorders
Antisense Therapies
Aptamer Therapies
DNA Vaccines
Electroporation
- Mirus: Transport Genes to Intracellular Targets
- Genteric Inc: Gene Pills
- CytRx and Merck: Transfection Technology Brings Milestone Payment
- Purdue: RNA-ATP Motors As Gene Delivery Vehicles?
- Athersys: Synthetic Microchromosomes
- Targeted Genetics: Large Genes Packaged in Adeno-Associated Virus
- Targeted Genetics: Synthetic Liposome Gene Delivery Slows Tumor Growth
- Valentis and Schering AG: Polymer Based Synthetic Gene Delivery
- University of South Carolina: Silica and Polystyrene Nanotubes for Gene Delivery?
- Washington University: Nano Polish Dumplings Carry DNA
- Rice University: Unraveling the Mystery of Membrane Fusion
- Stanford University: Integrase Makes Gene Therapy Safer
- University of California; Santa Barbara: Hydrogel Scaffolds for Gene Delivery
- Introgen: Adenoviral Vectors For Cancer Therapy
- Glygen: Glycoconjugates for Gene Therapy
Gene- and RNA-Regulation Therapies
- GenVec: TNF Gene Therapy Shrinks Tumors
- Ceregene: Growth Factor Genes for Neurologic Disorders
- Targeted Genetics: CF Gene Therapy
- Introgen: PTEN Gene Therapy For Restenosis And Melanoma
- Dynavax: Immunostimulatory DNA Sequences in Asthma Trials
- Hybridon: Tiny Pieces of DNA May Fight Infections; Cancers; and Inflammation
- Angiogenic Therapies: Blocking or Promoting Blood Vessel Growth
Genetically Engineered Cell Therapies
- Hybridon: Antisense Compound for Prostate Cancer
- Isis: Antisense for Crohn’s disease in Phase III
- Isis: Antisense for Pancreatic Cancer in Phase II
- Isis: Antisense Inhibitor of TNF-alpha in Phase II for Arthritis
- Isis/Lilly: Antisense Drug for Non-Small Cell Lung Cancer Disappoints
- Isis Regains Hepatitis Compound from Elan
- Genta: Antisense Drug for Colorectal Cancer Enters Clinical Trials
- AVI: Oral Antisense Agents
- AVI: Antisense Drug Protects Kidneys
- AVI: Antisense Drug Boosts Cancer Chemotherapy
- AVI: Antisense Vs. Restenosis
- AVI: Antisense Compound Prolongs Drug Half-Life
- AVI: Antisense Drug Prolongs Paclitaxel Life
- Acorda: Antisense Technology for Spinal Repair
- NovaRx: Antisense Cell Vaccine in Phase II Trial for Cancer
- EpiGenesis Pharmaceuticals: Antisense Targets Asthma Receptor
Gene Repair Technologies
- Duke University: Aptamers For The Rational Design Of Drug-Antidote Pairs
- Eyetech Pharmaceuticals: Anti-VEGF Aptamer Blocks Blood Vessel Growth
- Cyntellect and University of Texas: Thioaptamers Resist Bioterrorism
- Vitex: Aptamers To Remove Prions from Blood Products
- Genta Inc: Decoy Aptamers for Cancer
Research and Development in Europe
Research and Development in Asia Pacific
Product Innovation Award
Technology Transfer Award
Popular Topics
This report covers developments in gene therapy and DNA vaccines, including new technologies; novel applications; market analysis; and key developments
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | D260-01-00-00-00 |
Is Prebook | No |